about
Evaluation of a novel method to estimate absolute bioavailability of drugs from oral data.Atenolol exposure and risk for development of adverse metabolic effects: a pilot studyThe influence of gastrointestinal transit on drug absorption in healthy volunteersThe effect of ageing on the disposition of nifedipine and atenololAtenolol elimination in the neonate.Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.The combination of slow-release nifedipine and atenolol for stable angina.Pharmacokinetics of selective β1-adrenergic blocking agents: prescribing implications.Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.Evaluation of pharmacokinetic differences of acetaminophen in pseudo germ-free rats.Clinical pharmacokinetics of atenolol--a review.Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.Pharmacokinetics of acebutolol after intravenous bolus administration.Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers.Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist.Perturbation of upper gastrointestinal transit and antroduodenal motility by experimentally applied stress: the role of beta-adrenoreceptor mediated pathwaysAtenolol disposition in young and elderly subjects.Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum.The effect of atenolol, a beta1-adrenergic antagonist, on nocturnal plasma melatonin secretion: evidence for a dose-response relationship in humans.
P2860
Q30760138-692D9538-8714-4ECD-8631-DF0EB48F8047Q34394562-8B4B654F-D78C-4F59-8702-46B11E709ACAQ34403115-624405A9-4013-46FD-B61A-3424416ACFEAQ34417199-FAF623B9-16BD-4ED4-9F57-3FD71FFD48C6Q34514123-C2C95ECF-0887-464B-8707-8B28430190C2Q34761052-0A6A4E95-643A-4B90-B422-924A13998C0BQ36316489-FEE9F50C-C3C5-4762-BA57-C375556F4C85Q36400343-86C995D6-BF49-4155-A0A5-56DD1D33FF3BQ37782865-5CBBF7D4-B1CE-4C34-920F-79C6FE339776Q38226352-09436240-A811-480F-B7C0-8ACA294313F4Q38677027-C86C4481-C114-43D9-A587-F252ADD42FC7Q39239760-278543E3-3043-42D6-A456-ED77B68A902FQ39584435-7612A089-FD9B-4836-94AA-D971350DA47EQ40242958-B555B189-94B1-40FF-B899-B110E22194A3Q41893918-85707F7F-2390-4829-9E49-91A74D1CFBDFQ41909558-3F0EE24F-D51F-4F0F-94C7-CEEEA4724475Q42092581-9EBDEF3D-CD97-4CEE-A626-300812DF845FQ42202239-823FA17E-F697-43B1-AB57-CF720E93C30BQ42203753-3877E813-618E-4E7A-9E5D-1F8562D15445Q43241308-1FDCC134-226C-4D9A-910D-FAB35827DAC3Q45188816-66FFAD5C-1131-4E7F-B63A-40E33F28FD7FQ48580502-D4A2439B-DF91-4C1C-A3DF-68097468DB7B
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Kinetics and absolute bioavailability of atenolol.
@en
type
label
Kinetics and absolute bioavailability of atenolol.
@en
prefLabel
Kinetics and absolute bioavailability of atenolol.
@en
P2093
P356
P1476
Kinetics and absolute bioavailability of atenolol.
@en
P2093
P304
P356
10.1002/CPT1979254408
P407
P577
1979-04-01T00:00:00Z